GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (FRA:E4NA) » Definitions » Other Stockholders Equity

Arovella Therapeutics (FRA:E4NA) Other Stockholders Equity : €-0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arovella Therapeutics Other Stockholders Equity?

Arovella Therapeutics's Other Stockholders Equity for the quarter that ended in Jun. 2024 was €-0.00 Mil.

Arovella Therapeutics's quarterly Other Stockholders Equity increased from Jun. 2023 (€-0.00 Mil) to Dec. 2023 (€-0.00 Mil) but then declined from Dec. 2023 (€-0.00 Mil) to Jun. 2024 (€-0.00 Mil).

Arovella Therapeutics's annual Other Stockholders Equity declined from Jun. 2022 (€0.00 Mil) to Jun. 2023 (€-0.00 Mil) and declined from Jun. 2023 (€-0.00 Mil) to Jun. 2024 (€-0.00 Mil).


Arovella Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Arovella Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arovella Therapeutics Other Stockholders Equity Chart

Arovella Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Arovella Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Arovella Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Arovella Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Arovella Therapeutics Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics Headlines

No Headlines